[go: up one dir, main page]

DE3271862D1 - Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions - Google Patents

Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions

Info

Publication number
DE3271862D1
DE3271862D1 DE8282102163T DE3271862T DE3271862D1 DE 3271862 D1 DE3271862 D1 DE 3271862D1 DE 8282102163 T DE8282102163 T DE 8282102163T DE 3271862 T DE3271862 T DE 3271862T DE 3271862 D1 DE3271862 D1 DE 3271862D1
Authority
DE
Germany
Prior art keywords
leukocytes
chemokinesins
chemotaxins
pharmaceutical compositions
chemokinesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282102163T
Other languages
English (en)
Inventor
Josef H Dr Wissler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften
Priority to DE8282102163T priority Critical patent/DE3271862D1/de
Application granted granted Critical
Publication of DE3271862D1 publication Critical patent/DE3271862D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8282102163T 1981-03-18 1982-03-17 Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions Expired DE3271862D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8282102163T DE3271862D1 (en) 1981-03-18 1982-03-17 Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813110610 DE3110610A1 (de) 1981-03-18 1981-03-18 Chemokinesine und chemotaxine der leukozyten und des entzuendungsgewebes: natuerliche mediatoren zur selektiven reversiblen motilitaetsbeinflussung (chemokinesis) und chemische anlockung (chemotaxis) bei der ansammlung von leukozyten
DE8282102163T DE3271862D1 (en) 1981-03-18 1982-03-17 Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DE3271862D1 true DE3271862D1 (en) 1986-08-07

Family

ID=6127664

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19813110610 Withdrawn DE3110610A1 (de) 1981-03-18 1981-03-18 Chemokinesine und chemotaxine der leukozyten und des entzuendungsgewebes: natuerliche mediatoren zur selektiven reversiblen motilitaetsbeinflussung (chemokinesis) und chemische anlockung (chemotaxis) bei der ansammlung von leukozyten
DE8282102163T Expired DE3271862D1 (en) 1981-03-18 1982-03-17 Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19813110610 Withdrawn DE3110610A1 (de) 1981-03-18 1981-03-18 Chemokinesine und chemotaxine der leukozyten und des entzuendungsgewebes: natuerliche mediatoren zur selektiven reversiblen motilitaetsbeinflussung (chemokinesis) und chemische anlockung (chemotaxis) bei der ansammlung von leukozyten

Country Status (7)

Country Link
US (1) US4514387A (de)
EP (1) EP0061141B1 (de)
JP (1) JPS57167924A (de)
AT (1) ATE20590T1 (de)
AU (1) AU550626B2 (de)
DE (2) DE3110610A1 (de)
DK (1) DK118582A (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5538724A (en) * 1987-08-11 1996-07-23 The Board Of Trustees For The Leland Stanford Junior Univ. Method of control leukocyte extravasation
EP0303463B1 (de) * 1987-08-11 1994-11-30 The Board Of Trustees Of The Leland Stanford Junior University Verfahren zur Kontrolle der Leukozyten-Extravasation
US5403919A (en) * 1987-08-11 1995-04-04 Board Of Trustees Of The Leland Stanford Junior University Stanford University Method to control leukocyte extravasation
US6869924B1 (en) * 1989-01-31 2005-03-22 The United States Of America As Represented By The Department Of Health And Human Services Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof
IL92937A0 (en) * 1989-01-31 1990-09-17 Us Health Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
DE69331580T2 (de) * 1992-09-25 2002-08-14 The Australian National University, Acton Nachweis von beweglichen zellen in einer probe
CZ5191U1 (cs) * 1993-07-12 1996-09-12 Aliatros Medical, A.S. Farmaceutický prostředek pro imunomodulační a adjuvantní léčbu
US6833271B2 (en) * 1996-12-04 2004-12-21 Medi-Cult A/S Serum-free cell culture media
WO1998039013A1 (en) * 1997-03-04 1998-09-11 Peregrine Pharmaceutical, Inc. Composition and method for treating cancer and immunological disorders resulting in chronic conditions
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
WO1999066797A1 (en) 1998-06-22 1999-12-29 Worden Charles E Enriched platelet wound healant
JP2003527603A (ja) * 2000-03-16 2003-09-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ケモキネシス誘導物質のアッセイ
US20050260752A1 (en) * 2003-04-01 2005-11-24 Wilding Martin G Culture medium containing enhancers of oxidative phosphorylation
EP1890820A4 (de) * 2005-03-22 2012-04-11 Cascade Medical Entpr Llc Systeme und verfahren zur herstellung von membranen
EP3554257B1 (de) 2016-12-15 2023-07-12 Société des Produits Nestlé S.A. Zusammensetzungen und verfahren zur modulation von weissen blutkörperchen oder neutrophilen in einem haustier

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3009126A1 (de) 1980-03-10 1981-10-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von funktionell und morphologisch intakten und lebensfaehigen leukozyten aus blut

Also Published As

Publication number Publication date
EP0061141A3 (en) 1983-09-14
EP0061141A2 (de) 1982-09-29
DE3110610A1 (de) 1982-10-28
DK118582A (da) 1982-09-19
ATE20590T1 (de) 1986-07-15
JPS57167924A (en) 1982-10-16
AU550626B2 (en) 1986-03-27
AU8163282A (en) 1982-09-23
EP0061141B1 (de) 1986-07-02
US4514387A (en) 1985-04-30

Similar Documents

Publication Publication Date Title
DE3271862D1 (en) Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions
AU550434B2 (en) Angiotropins of leukocytes and inflamed tissues
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
EP0339237A3 (de) Phenol-substituierte Gem-Diphosphonat-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
MY102472A (en) Preparation of funtional human urokinase proteins.
AU600688B2 (en) Insecticidal pyrazolines
IE960853L (en) Vascular anticoagulant proteins
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
ATE297750T1 (de) Verwendung von hsp70 protein
BR0114847A (pt) Sequências de ácido nucléico para proteìnas envolvidas em sìntese de tocoferol
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
AU3927189A (en) N-2,3-butadienyl tri- and tetraaminoalkane derivatives
MA21588A1 (fr) Derives d'ether de n-pheryl pyrazole-4-yle, compositions les contenant et leur procede de preparation.
AU1828388A (en) Promoters for the expression of foreign dna in methylotrophic bacteria, the obtaining thereof and the use thereof
ATE17738T1 (de) Mitogene aus leukozyten und entzuendeten geweben: natuerliche leukopoietische proteine fuer die spezifische induktion der vermehrung und der differenzierung von leukozyten; verfahren zu ihrer biotechnischen herstellung und pharmazeutische zusammensetzungen.
FR2556721B1 (fr) Nouveaux derives de o-mercaptopropanamide d'o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2573077B1 (fr) Nouveaux derives thiosulfonates, leur procede de preparation ainsi que les compositions pharmaceutiques les contenant
FR2595697B1 (fr) Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
EP0061140A3 (en) Chemorecruitins of leukocytes and inflamed tissues: a new class of natural leukopoietin proteins for chemorecruitment of specific leukocyte types from the bone marrow into blood circulation (leukocytosis and leftward shift reactions), process for their biotechnical preparation and pharmaceutical compositions
ATE87977T1 (de) Herstellung menschlichen somatomedins c.
FR2598423B1 (fr) Produit a base d'elastine, procede pour sa preparation et ses applications biologiques, en particulier en tant que biomateriaux et supports artificiels
AU2347501A (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
EP0315081A3 (en) Anti-coagulating protein pp4-x, its preparation and use
FR2559157B1 (fr) Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee